National Center for Complementary & Alternative Medicine; Notice of Meeting, 14700 [05-5669]
Download as PDF
14700
Federal Register / Vol. 70, No. 55 / Wednesday, March 23, 2005 / Notices
in at the security desk upon entering the
building.
Information is also available on the
Institute’s/Center’s home page: www.nih.gov/
od/oar/index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Democracy Blvd., Suite 401, Bethesda, MD
20892, (301) 496–6701.
Copies of the meeting agenda and the
roster of members will be furnished upon
request by contacting Dr. Jane Kinsel,
Executive Secretary, NACCAM, National
Institutes of Health, 6707 Democracy
Boulevard, Suite 401, Bethesda, Maryland
20892, 301–496–6701, Fax 301–480–0087, or
via e-mail at naccames@mail.nih.gov.
Dated: March 15, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–5665 Filed 3–22–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Meeting
Pursuant to Section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the National Advisory
Council for Complementary and
Alternative Medicine (NACCAM)
meeting.
This meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussion could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Alternative
Medicine.
Date: July 29, 2005.
Closed: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: 6707 Democracy Boulevard, Two
Democracy, Room 401, Bethesda, Maryland
20892, (Telephone Conference Call).
Contact Person: Jane F. Kinsel, PhD,
M.B.A., Executive Secretary, National Center
for Complementary and Alternative
Medicine, National Institutes of Health, 6707
VerDate jul<14>2003
16:27 Mar 22, 2005
Jkt 205001
Dated: March 16, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy, NIH.
[FR Doc. 05–5668 Filed 3–22–05; 8:45 am]
Dated: March 16, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy, NIH.
[FR Doc. 05–5669 Filed 3–22–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
BILLING CODE 4140–01–M
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Meeting
Pursuant to Section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the National Advisory
Council for Complementary and
Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Advisory
Council for Complementary and Alternative
Medicine.
Date: April 4, 2005.
Open: 12:30 p.m. to 2:30 p.m.
Agenda: The agenda includes Opening
Remarks by Director, NCCAM, and a Concept
for Milk Thistle RFA.
Place: 6707 Democracy Boulevard, Two
Democracy, Room 401, Bethesda, Maryland
20892, (Telephone Conference Call).
Contact Person: Jane F. Kinsel, Executive
Secretary, National Center for
Complementary and Alternative Medicine,
National Institutes of Health, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20892, (301) 496–6701.
The meeting is being published less than
15 days prior to the meeting due to
scheduling conflicts.
Copies of the meeting agenda and the
roster of members will be furnished upon
request by contacting Dr. Jane Kinsel,
Executive Secretary, NACCAM, National
Institutes of Health, 6707 Democracy
Boulevard, Suite 401, Bethesda, Maryland
20892, 301–496–6701, Fax 301–480–0087, or
via e-mail at naccames@mail.nih.gov.
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5,
U.S.C., as amended. The contract
proposals and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Loan Repayment Program (L30 and L40s).
Date: April 8, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Jamie Varghese, PhD,
Health Science Administrator, DHVD/HRP,
NIH/NHLBI, Rockledge 2, Room 9204, 6701
Rockledge Drive, Bethesda, MD 20892–7950,
301–435–0510, varghesej@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Disorders Research; 93.837, Heart and
Vascular Disease Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 15, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–5660 Filed 3–22–05; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\23MRN1.SGM
23MRN1
Agencies
[Federal Register Volume 70, Number 55 (Wednesday, March 23, 2005)]
[Notices]
[Page 14700]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-5669]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Alternative Medicine; Notice
of Meeting
Pursuant to Section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the National
Advisory Council for Complementary and Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
Name of Committee: National Advisory Council for Complementary
and Alternative Medicine.
Date: April 4, 2005.
Open: 12:30 p.m. to 2:30 p.m.
Agenda: The agenda includes Opening Remarks by Director, NCCAM,
and a Concept for Milk Thistle RFA.
Place: 6707 Democracy Boulevard, Two Democracy, Room 401,
Bethesda, Maryland 20892, (Telephone Conference Call).
Contact Person: Jane F. Kinsel, Executive Secretary, National
Center for Complementary and Alternative Medicine, National
Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD
20892, (301) 496-6701.
The meeting is being published less than 15 days prior to the
meeting due to scheduling conflicts.
Copies of the meeting agenda and the roster of members will be
furnished upon request by contacting Dr. Jane Kinsel, Executive
Secretary, NACCAM, National Institutes of Health, 6707 Democracy
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-496-6701, Fax
301-480-0087, or via e-mail at naccames@mail.nih.gov.
Dated: March 16, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 05-5669 Filed 3-22-05; 8:45 am]
BILLING CODE 4140-01-M